期刊文献+

促排卵中多卵泡发育者改行IVF-ET的分析 被引量:2

Analysis of IVF-ET in patients with multi-follicle development induced ovulation
下载PDF
导出
摘要 目的探讨促排卵中多卵泡发育者的积极处理方法,保持受孕机会的同时减少卵巢过度刺激综合征(ovarian hyperstimulation syndrome,OHSS)和多胎妊娠的风险。方法对于克罗米酚(clomiphene citrate,CC)或人绝经后促性腺激素(human menopausal gonodatropin,hMG)促排卵中发生多卵泡发育的15例患者,采用改行体外受精-胚胎移植(in vitrofertilization and embryo transfer,IVF-ET)的方法进行处理。结果改行IVF-ET者与本中心同期同年龄组行常规IVF-ET者相比,其受精率分别为67.21%对74.17%,卵裂率分别为90.24%对95.79%,取卵周期妊娠率分别为26.67%对37.65%,移植周期妊娠率分别为36.36%对40.13%,上述数据均无统计学差异(P>0.05),15例患者中无一发生OHSS,说明改行IVF-ET可以作为促排卵中多卵泡发育的一种积极处理方法。结论促排卵治疗中出现多卵泡发育时,行IVF-ET可能是有效、安全的治疗方法。 Objective To study the therapy methods of multi-follicle development during induced ovulation, in order to have the possibility of being pregnant and reduce the risk of ovarian hyperstimulation syndrome (OHSS) and multiple pregnancies at the same time. Methods Methods of in vitro fertilization and embryo transfer (IVF-ET) was used to treat 15 patients of multi-follicle development during induced ovulation by clomiphene citrate (CC) or human menopausal gonodatropin (hMG). Results The pregnancy rate of ovum pick-up (OPU) period and pregnancy rate of embryo transfer (ET) period of IVF group was 26.67%, 36.36% respectively. No statistic difference was observed as compared with the same age group receiving regular IVF-ET. No OHSS occurred. Conclusion Method of IVF-ET was effective and energetic for multi-follicle development during induced ovulation.
出处 《同济大学学报(医学版)》 CAS 2009年第1期56-59,共4页 Journal of Tongji University(Medical Science)
基金 上海市卫生局青年科技基金资助项目(054Y09)
关键词 多卵泡发育 体外受精-胚胎移植 卵母细胞体外成熟 multi-follicle development IVF-ET IVM
  • 相关文献

参考文献7

  • 1Van-Wely M, Yding-Andersen C, Bayram N, et al. Urofollitropin and ovulation induction [ J ]. Treatm Endocrinol,2005,4(3 ) : 155 - 165.
  • 2沈澄洁,黄冰清,李怀芳.阴道斜膈综合征临床分析[J].同济大学学报(医学版),2008,29(1):90-92. 被引量:3
  • 3Palomba S, Orio F, Falbo A, et al. Clomiphene citrate versus metformin as first-line approach for the treatment of anovulation in infertile patients with polycystic ovary syndrome[J]. J Clin Endocrinol & Metabolism,2007,92 (9) : 3498 - 3503.
  • 4Farquhar CM. An economic evaluation of ovarian diathermy versus gonadotrophin laparoscopic therapy for women with clomiphene citrate-resistant polycystic ovarian syndrome [ J ]. Current Opinion Obstetrics & Gynecol,2005,17(4) : 347 - 353.
  • 5Hugues JN, Cedrin-Durnerin I, Howles CM, et al. The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO group Ⅱ anovulation: a prospective randomized multicentre study[ J]. Human Reproduction, 2006,21 ( 11 ) : 2817 - 2822.
  • 6Al-Inany H, Aboulghar MA, Mansour RT, et al. Ovulation induction in the new millennium: recombinant follicle-stimulating hormone versus human menopausal gonadotropin [ J ]. Gynecol Endocrinol, 2005,20 ( 3 ) : 161 - 169.
  • 7钱云,刘嘉茵,冯婷,陈娟,蔡令波,冒韵东,丁卫,张燕.未成熟卵体外成熟技术在卵巢反应不良和卵泡发育迟缓周期中的应用[J].中国实用妇科与产科杂志,2005,21(4):217-219. 被引量:6

二级参考文献18

  • 1洪丽华,金杭美.女性生殖道畸形患者发生泌尿系统畸形的临床特点分析[J].中华妇产科杂志,2004,39(8):515-518. 被引量:34
  • 2曹泽毅.中华妇产科学[M].北京:人民卫生出版社,1996.1885.
  • 3Anasti JN. Premature ovarian faliure: an update. Fertil Steril, 1998,70:1-15.
  • 4Cobo AC,Requene A,Neuspiller F,et al. Maturation in vitro of human oocytes from unstimulated cycles:selection of the optimal day of ovum retrieval based on follicular size. Hum Reprod, 1999,14 (7) :1864-1868.
  • 5Cha KY, Koo JJ,Choi DH,et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles,their culture in vitro and their transfer in a donor oocyte program. Fertil Steril, 1991,55 ( 1 ) : 109-113.
  • 6Ben-Rafeal Z, Menashe Y, Mimon R, et al. Limitations in the use of combined gonadotropin-releasing hormone analog and human menopausal gonadotropin for in vitro fertilization. In : Mashiach S, Ben-Rafael Z, Laufer N, eds. Advances in assisted reproductive technologies. New York ( NY, USA) : Plenum Press, 1990.17-30.
  • 7Van Hooff MHA, Alberda AT, Huisman GJ, et al. Doubling the human menopausal gonadotropin dose in the course of an in vitro fertilization treatment cycles in low responders:a randomized study. Hum Reprod, 1993,8 : 369-73.
  • 8Barri PN, Martinez F,Coroleu B,et al. Managing nonresponders. In:Kempers RD, Cohen J, Haney AF, eds. Proceedings of the XVI World Congress on Fertil Steril. San Francisco, Amsterdam: Elsevier, 1998.27-37.
  • 9Lashen H,Ledger W, Lopez-Bernal A,et al. Poor responders to ovulation induction: is proceeding to in vitro fertilization worth-while?Hum Reprod, 1999,14:964-9.
  • 10Meyer WR, Lunenfeld B, Eshel A, et al. Evidence of gonadal and gonadotrophin antibodies in woman with a suboptimal ovarian reponse to exogenous gonadotrophin. Fertil Steril,1990,75(5) :795-799.

共引文献7

同被引文献22

  • 1蒋小红,靳镭.GnRH antagonist治疗多囊卵巢综合征的IVF-ET结局[J].中国优生与遗传杂志,2007,15(3):98-100. 被引量:5
  • 2Revised 2003 consensus on diagnostic criteria and long-term health risksrelated to polycystic ovary syndrome. Fertil Steril,2004,81:19-25.
  • 3Stanger JD, Yovich JL. Reduced in-vitro fertilization of human oocytesfrom patients with raised basal luteinizing hormone levels during thefollicular phase. Br J Obstet Gynaecol, 1985,92 : 385-393.
  • 4Tavaniotou A,Albano C,Van Steirteghem A,et al. The impact of LH ser-um concentration on the clinical outcome of IVF cycles in patients receiv-ing two regimens of clomiphene citrate/gonadotrophin/0. 25 rag cetrorel-ix. Reprod Biomed Online,2003,6: 421-426.
  • 5Olivennes F,Belaisch-Allart J,Emperaire JC,et al. Prospective,random-ized ,controlled study of in vitro fertilization-embryo transfer with a singledose of a luteinizing hormone-releasing hormone ( LH-RH) antagonist(cetrorelix) or a depot formula of an LH-RH agonist (triptorelin). FertilSteril,2000,73:314-320.
  • 6Engel JB,Ludwig M,Felberbaum R,et al. Use of cetrorelix in combina-tion with clomiphene citrate and gonadotrophins : a suitable approach to friendly IVF: Hum Reprod ,2002,17 .*2022-2026.
  • 7Lainas TG,Sfontouris IA,Zorzovilis IZ,et al. Flexible GnRH antagonistprotocol versus GnRH agonist long protocol in patients with polycystic o-vary syndrome treated for IVF : a prospective randomised controlled trial(RCT).Hum Reprod,2010,25:683-689.
  • 8Lin YH,Seow KM,Hsieh BC,et al. Application of GnRH antagonist incombination with clomiphene citrate and hMG for patients with exagger-ated ovarian response in previous IVF/ICSI cycles. J Assist Reprod Gen-et,2007,24;331-336.
  • 9张金玉,葛明晓,郭新宇,李文玲,于妍,谢素嫣.常规促排卵与GnRHα降调节促排卵后IVF-ET治疗多囊卵巢综合征比较[J].现代妇产科进展,2008,17(3):209-210. 被引量:2
  • 10杨美琼,全松,李红,宋亚丽,邢福祺.两种不同剂量来曲唑对多囊卵巢综合征不孕患者促排卵的对照研究[J].南方医科大学学报,2008,28(11):2060-2062. 被引量:18

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部